Publications by authors named "Rodney Prell"

Claim this Profile
Q
Quantifying Risk of Delayed QT Prolongation of Ipatasertib in Preclinical and Clinical Studies in Cancer Patients.
Victor Poon, Dhruvitkumar Sutaria, Rodney Prell, Wendy Halpern, Lisa Wong

Clin Transl Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the impact and risk of immunomodulatory compounds on pregnancy.
Joanne Kwak-Kim, Curtis C Maier, Caren M Villano, Christopher J Bowman, Frank R Brennan, Rodney A Prell

J Reprod Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current nonclinical approaches for immune assessments of immuno-oncology biotherapeutics.
Christine Grimaldi, Alex Ibraghimov, Andrea Kiessling, Benno Rattel, Changhua Ji, Rodney Prell

Drug Discov Today· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing the drug development and therapeutic paradigm with biologic drug combinations and bispecifics: How to choose between these two approaches?
Songmao Zheng, Rodney Prell, Jennifer Sheng, Yow-Ming Wang, Lora Hamuro

Clin Transl Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a nonhuman primate challenge model to evaluate CD8 T cell responses to an adenovirus-based vaccine expressing SIV proteins upon repeat-dose treatment with checkpoint inhibitors.
Richard Graveline, Morad Haida, Carolyne Dumont, Dominic Poulin, Florence Poitout-Belissent, Rodney Prell

MAbs· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody.
Karin Staflin, Christina L Zuch de Zafra, Leah K Schutt, Vanessa Clark, Fiona Zhong, Rodney Prell

JCI Insight· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Assessment of Antibody-Dependent Enhancement of Influenza B Infection.
Gautham K Rao, Rodney A Prell, Steven T Laing, Stefanie C M Burleson, Allen Nguyen

Toxicol Sci· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resolution of unexpected pregnancy-related findings in a rat embryofetal development and toxicokinetic study of monoclonal antibodies specific for hCMV.
Paula Katavolos, Rodney Prell, Doris Zane, Rong Deng, Wendy Halpern

Birth Defects Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3.
Dionysos Slaga, Diego Ellerman, T Noelle Lombana, Rajesh Vij, Ji Li, Rodney Prell

Sci Transl Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placental and Fetal Effects of Onartuzumab, a Met/HGF Signaling Antagonist, When Administered to Pregnant Cynomolgus Monkeys.
Rodney A Prell, Noel Dybdal, Akihiro Arima, Yutaka Chihaya, Ihsan Nijem

Toxicol Sci· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An anti-CD3/anti-CLL-1 bispecific antibody for the treatment of acute myeloid leukemia.
Steven R Leong, Siddharth Sukumaran, Maria Hristopoulos, Klara Totpal, Shannon Stainton, Rodney A Prell

Blood· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspective on a Modified Developmental and Reproductive Toxicity Testing Strategy for Cancer Immunotherapy.
Rodney A Prell, Wendy G Halpern, Gautham K Rao

Int J Toxicol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies.
Gabriele Schaefer, Lauric Haber, Lisa M Crocker, Steven Shia, Lily Shao, Rodney A Prell

Cancer Cell· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease.
Keith S Bahjat, Rodney A Prell, Heather E Allen, Weiqun Liu, Edward E Lemmens

J Immunol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
Betty Li, Alshad S Lalani, Thomas C Harding, Bo Luan, Kathryn Koprivnikar, Rodney Prell

Clin Cancer Res· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration.
Rodney A Prell, Lisa Gearin, Andrew Simmons, Melinda Vanroey, Karin Jooss

Cancer Immunol Immunother· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma.
Yiwei Chu, Li-Xin Wang, Guojun Yang, Helen J Ross, Walter J Urba, Rodney Prell

J Immunother· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of IFN-alpha enhances the efficacy of a granulocyte macrophage colony stimulating factor-secreting tumor cell vaccine.
Rodney A Prell, Betty Li, Jian Min Lin, Melinda VanRoey, Karin Jooss

Cancer Res· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement.
Andrew D Weinberg, Dean E Evans, Colin Thalhofer, Tom Shi, Rodney A Prell

J Leukoc Biol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OX40-mediated memory T cell generation is TNF receptor-associated factor 2 dependent.
Rodney A Prell, Dean E Evans, Colin Thalhofer, Tom Shi, Castle Funatake

J Immunol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis